Liposomal drug formulations. Rationale for development and what we can expect for the future (Q40834304)
scientific article
Language:
(P31) (Q13442814)
(P304) 747-756
(P407) (Q1860)
(P433) 5
(P478) 56
(P577) Sunday, November 1, 1998
(P1433) (Q3040094)
(P1476) "Liposomal drug formulations. Rationale for development and what we can expect for the future" (language: en)
(P2093) Allen TM
(P2860) (Q41336831)
(Q41564259)
(Q72660484)
(Q41444558)
(Q73224907)
(Q73202226)
(Q72818206)
(Q73450823)
(Q73219443)
(Q41017576)
(Q72428433)
(Q72785658)
(Q46136376)
(Q73326509)
(Q49155918)
(Q45976411)
(Q70742601)
(Q41434734)
(Q41465260)
(Q40902814)
(Q55479042)
(Q41607838)
(Q45994601)
(Q40530985)
(Q37870070)
(Q71566289)
(Q41403732)
(Q40651587)
(Q70866626)
(Q77554062)
(Q58069205)
(Q72851913)
(Q36138642)
(Q46391939)
(Q41892948)
(Q52272798)
(Q44041827)
(Q72133351)
(Q71706209)
(Q72927459)
(Q37589185)
(Q40499095)
(Q56770788)
(Q71221688)
(Q57221315)
(Q73182772)
(Q71111853)
(Q40462719)
(Q41608176)
(Q72317822)
(Q73502164)
(Q70720803)
(Q71920419)
(P13046) (Q7318358)